Accessibility Menu
P3 Health Partners logo

P3 Health Partners(NASDAQ) PIII

Current Price$9.78
Market Cap$31.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-98%
5 Year-98%
1 Year+30%
1 Month-14%
P3 Health Partners last closing stock price
MetricPriceDate
Last closeUSD 9.622026-07-24
P3 Health Partners stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-11.09%USD 10.822026-07-17
1 month-13.64%USD 11.142026-06-24
3 month+264.39%USD 2.642026-04-24
Year to date+175.64%USD 3.492025-12-31
1 year+30%USD 7.402025-07-24
3 year-91.95%USD 119.502023-07-25
5 year-98.05%USD 493.502021-07-23
Since inception-98.01%USD 484.042021-04-06

P3 Health Partners Financials at a Glance

Market Cap

$31.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.47B

Net Income (TTM)

-$126.25M

EPS (TTM)

-$38.60

P/E Ratio

-0.25

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$9.78

Volume

442

Open

$9.71

Previous Close

$9.78

Daily Range

$9.68 - $9.88

52-Week Range

$1.52 - $16.89

Estimated Earnings Date

Aug 13, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About P3 Health Partners

P3 Health Partners helps older adults manage their health through local clinics and physician networks. The company coordinates care for people enrolled in Medicare Advantage, a government-backed health plan. Its services aim to make healthcare easier and more effective for patients and doctors.

What’s in the P3 Toolbox?

  • Population Health Management (98% of revenue): Coordinates care for Medicare Advantage members, focusing on preventive and ongoing health needs.
  • Primary Care Clinics: Runs clinics and wellness centers for direct patient care, mainly serving older adults.
  • Affiliate Physician Network: Partners with local doctors to expand reach and maintain patient relationships.
  • Delegated Services: Handles tasks for health insurers, such as claims processing and care management.
  • P3 Technology/Health Hub: Offers a digital platform for doctors to track patient data and manage care plans.

Growth Moves: P3’s Expansion Playbook

  • Sold Florida assets in 2024 and 2025 to focus on core markets.
  • Formed P3 Commonwealth Innovation MSO, LLC in November 2025 for new care management activities.
  • Expanded into Arizona, California, Nevada, and Oregon by 2025.
  • Invested in proprietary technology and care management infrastructure throughout 2024 and 2025.
  • Raised $39.8 million in a private placement in May 2024 to support operations.

Why P3 Stands Out (Without the Hype)

P3 focuses on value-based care, where doctors are paid for keeping patients healthy, not just for each visit. Its affiliate model lets local doctors stay independent while joining a larger network. The company’s technology platform helps doctors manage patient care more efficiently.

Five Things You Need to Know

  • Revenue was $1.46 billion in 2025, down 3% from 2024.
  • Capitated revenue made up 98% of total revenue in 2025.
  • Net loss was $323.1 million in 2025, with a -22% margin.
  • Four health plans accounted for 75% of revenue in 2025.
  • Cash and cash equivalents were $25 million as of December 31, 2025.

Bottom Line

P3 has built a regional network for managing care of older adults in the U.S. The company faces ongoing financial challenges but continues to adapt its business model and focus on core markets.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Employees

320

CEO

Aric Coffman, MD, MBA

Headquarters

Henderson, NV 89074, US

PIII Financials

Key Financial Metrics (TTM)

Gross Margin

50.63%

Operating Margin

-15.21%

Net Income Margin

-8.57%

Return on Equity

184.97%

Return on Capital

-208.48%

Return on Assets

-18.73%

Earnings Yield

-4.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$31.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.33M

Volume

442

Avg. Volume

1.29M

Financials (TTM)

Gross Profit

$745.36M

Operating Income

-$223.98M

EBITDA

-$138.59M

Operating Cash Flow

-$85.24M

Capital Expenditure

$79.00K

Free Cash Flow

-$85.16M

Cash & ST Invst.

$25.50M

Total Debt

$62.27M

P3 Health Partners Performance Analysis

P3 Health Partners annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,049,471,00064.7%
20232023-12-31USD 1,266,375,00020.7%
20242024-12-31USD 1,500,455,00018.5%
20252025-12-31USD 1,459,080,000-2.8%
P3 Health Partners sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-4.7%
Q32025-09-30-3.0%
Q42025-12-3111.5%
Q12026-03-310.4%
P3 Health Partners annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -324.8472.6%
20232023-12-31USD -30.44-90.6%
20242024-12-31USD -54.0677.6%
20252025-12-31USD -45.26-16.3%
P3 Health Partners sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-300.8%
Q32025-09-30-55.2%
Q42025-12-31-138.1%
Q12026-03-31101.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$386.39M

+3.5%

Gross Profit

$29.29M

+606.8%

Gross Margin

7.58%

N/A

Market Cap

$31.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$99.98K

N/A

Employees

320

N/A

Net Income

$1.22M

+106.0%

EBITDA

$29.88M

+323.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$25.50M

-36.4%

Total Debt

$62.27M

-66.0%

Accounts Receivable

$124.89M

-7.3%

Inventory

$0.00

N/A

Long Term Debt

$10.83M

-90.8%

Short Term Debt

$51.44M

-21.8%

Return on Assets

-18.73%

N/A

Return on Invested Capital

-1.51%

N/A

Free Cash Flow

-$27.47M

+17.9%

Operating Cash Flow

-$27.47M

+17.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TLPHTalphera, Inc.
$1.35-1.46%
IBIOiBio, Inc.
$1.43+2.14%
HYPDHyperion DeFi, Inc.
$2.51-4.92%
TAOXTAO Synergies Inc.
$3.29-10.35%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About PIII

What is the current price of P3 Health Partners?

P3 Health Partners is trading at $9.78 per share.

What is the 52-week range for P3 Health Partners?

Over the past 52 weeks, P3 Health Partners has traded between $1.52 and $16.89.

How much debt does P3 Health Partners have?

As of the most recent reporting period, P3 Health Partners reported total debt of $322.67M.

How much cash does P3 Health Partners have on hand?

P3 Health Partners reported $26.10M in cash and cash equivalents in its most recent financial results.

What is P3 Health Partners’s dividend yield?

P3 Health Partners does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.